Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 4
2006 3
2007 9
2008 14
2009 11
2010 16
2011 20
2012 17
2013 28
2014 20
2015 22
2016 19
2017 26
2018 30
2019 14
2020 17
2021 21
2022 5
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

252 results

Results by year

Filters applied: . Clear all
Page 1
Neutral Sphingomyelinase 2 Inhibition Limits Hepatic Steatosis and Inflammation.
Al-Rashed F, Arefanian H, Madhoun AA, Bahman F, Sindhu S, AlSaeed H, Jacob T, Thomas R, Al-Roub A, Alzaid F, Malik MDZ, Nizam R, Thanaraj TA, Al-Mulla F, Hannun YA, Ahmad R. Al-Rashed F, et al. Cells. 2024 Mar 6;13(5):463. doi: 10.3390/cells13050463. Cells. 2024. PMID: 38474427 Free PMC article.
Targeting sphingosine kinase 1 in p53KO thymic lymphoma.
Velazquez FN, Stith JL, Zhang L, Allam AM, Haley J, Obeid LM, Snider AJ, Hannun YA. Velazquez FN, et al. FASEB J. 2023 Nov;37(11):e23247. doi: 10.1096/fj.202301417R. FASEB J. 2023. PMID: 37800872
A novel HSPB1S139F mouse model of Charcot-Marie-Tooth Disease.
Espinoza KS, Hermanson KN, Beard CA, Schwartz NU, Snider JM, Low BE, Wiles MV, Hannun YA, Obeid LM, Snider AJ. Espinoza KS, et al. Prostaglandins Other Lipid Mediat. 2023 Dec;169:106769. doi: 10.1016/j.prostaglandins.2023.106769. Epub 2023 Aug 23. Prostaglandins Other Lipid Mediat. 2023. PMID: 37625781
Ceramide as an endothelial cell surface receptor and a lung-specific lipid vascular target for circulating ligands.
Staquicini DI, Cardó-Vila M, Rotolo JA, Staquicini FI, Tang FHF, Smith TL, Ganju A, Schiavone C, Dogra P, Wang Z, Cristini V, Giordano RJ, Ozawa MG, Driessen WHP, Proneth B, Souza GR, Brinker LM, Noureddine A, Snider AJ, Canals D, Gelovani JG, Petrache I, Tuder RM, Obeid LM, Hannun YA, Kolesnick RN, Brinker CJ, Pasqualini R, Arap W. Staquicini DI, et al. Proc Natl Acad Sci U S A. 2023 Aug 22;120(34):e2220269120. doi: 10.1073/pnas.2220269120. Epub 2023 Aug 14. Proc Natl Acad Sci U S A. 2023. PMID: 37579172 Free PMC article.
Neutral ceramidase-active site inhibitor chemotypes and binding modes.
Coant N, Bickel JD, Rahaim R, Otsuka Y, Choi YM, Xu R, Simoes M, Cariello C, Mao C, Saied EM, Arenz C, Spicer TP, Bannister TD, Tonge PJ, Airola MV, Scampavia L, Hannun YA, Rizzo RC, Haley JD. Coant N, et al. Bioorg Chem. 2023 Oct;139:106747. doi: 10.1016/j.bioorg.2023.106747. Epub 2023 Jul 27. Bioorg Chem. 2023. PMID: 37531819 Free PMC article.
252 results